pubmed.ncbi.nlm.nih.gov

A prospective study of circulating adipokine levels and risk of multiple myeloma - PubMed

  • ️Sun Jan 01 2012

Multicenter Study

A prospective study of circulating adipokine levels and risk of multiple myeloma

Jonathan N Hofmann et al. Blood. 2012.

Abstract

It has been hypothesized that the observed excess risk of multiple myeloma (MM) among obese persons could be the result of altered circulating levels of adipokines, polypeptide hormones with pro- and anti-inflammatory properties secreted by adipose tissue. We investigated whether circulating levels of leptin, total adiponectin, and high molecular weight adiponectin are associated with subsequent MM risk among 174 MM patients and 348 controls within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Inverse associations with MM were observed for total adiponectin (highest quartile vs lowest: odds ratio = 0.49; 95% CI = 0.26-0.93, P(trend) = .03) and high molecular weight adiponectin (0.44; 0.23-0.85, P(trend) = .01). These associations remained after restricting to MM patients diagnosed ∼ 8 years or more after blood collection. Leptin levels were not associated with MM risk. The results of this study, to our knowledge the first prospective investigation of circulating adipokines and MM, suggest that adiponectin may play an important role in obesity-related myelomagenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Risk of MM in relation to prediagnostic circulating levels of total adiponectin, HMW adiponectin, and leptin in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Similar articles

Cited by

References

    1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
    1. Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412–5417. - PMC - PubMed
    1. De Roos AJ, Baris D, Weiss NS, Herrinton LJ. Multiple myeloma. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. 3rd Ed. New York, NY: Oxford University Press; 2006. pp. 919–945.
    1. Alexander DD, Mink PJ, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl 12):40–61. - PubMed
    1. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47(11):1606–1615. - PubMed

Publication types

MeSH terms

Substances